Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42) - Image 1

£107.85

Springer Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Name: Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
Brand: Springer
Price: 107.27 GBP
Availability: InStock

Oncology

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £107

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical

Generating forecast...

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £107 (73 days, 81.1%)

Price range: £107 - £108

Price levels: 2 different prices over 90 days

Description

Experimental chemotherapy continues to be at the forefront of cancer thera peutics. Topics covered in the preceding volume on cancer chemotherapy in this series such as study of drugs by alkaline elution, the development of the antimetabolite tiazofurin, and the treatment of germ cell tumors have become informative references to current experimentalists and practitioners. In even earlier volumes, reviews of the platinum compounds, anthracyclines, and osteosarcoma represent topics associated with such rapid progress requiring a look back to provide the appropriate perspective. Similarly, we venture to predict that the topics in this volume will become useful landmarks for future drug development and disease strategies. In the area of drug development, what is being learned about old, estab lished antineoplastics is raising renewed expectations that it will be translated into improved applications and patient benefit. For example, we now have the ability to modulate the action of alkylating agents and fluorinated pyri midines to achieve greater sensitivity. A new compound for an old target, trimetrexate, an antifolate that does not polyglutaminate, will have a role not only in treatment of neoplastic diseases, but also protozoal infection.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1461289815
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Publication Date: 05 October 2011
Listed Since: 21 December 2012

Barcode

No barcode data available

Springer Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Metronomic Chemotherapy: Pharmacology and Clinical Applications

Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Cancer II: 28 (Topics in Medicinal Chemistry, 28)

Cancer Drug Discovery: Science and History

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Organ Directed Toxicities of Anticancer Drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer ... 4–6, 1987: 53 (Developments in Oncology, 53)

Gene-Based Therapies for Cancer (Current Cancer Research)

Oncologic Therapies

Nutraceuticals and Cancer

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Cancer Clinical Trials: Proactive Strategies: 132 (Cancer Treatment and Research, 132)

Pathobiology of Cancer Regimen-Related Toxicities

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Advances in Endophytic Research

Emerging Therapeutic Targets in Ovarian Cancer

Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies

Enzyme-Prodrug Strategies for Cancer Therapy

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Natural Products and Cancer Drug Discovery (Cancer Drug Discovery and Development)